STRATA Skin Sciences, Inc. Stock BOERSE MUENCHEN
Equities
E2O
US86272A3059
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 EUR | -17.65% |
|
0.00% | 0.00% |
May. 15 | STRATA Skin Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Transcript : STRATA Skin Sciences, Inc., Q1 2024 Earnings Call, May 15, 2024 |
Sales 2024 * | 31.16M 29.09M | Sales 2025 * | 33.82M 31.57M | Capitalization | 10.76M 10.05M |
---|---|---|---|---|---|
Net income 2024 * | -10M -9.34M | Net income 2025 * | -5M -4.67M | EV / Sales 2024 * | 0.35 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.32 x |
P/E ratio 2024 * |
-1.1
x | P/E ratio 2025 * |
-1.98
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.41% |
Latest transcript on STRATA Skin Sciences, Inc.
Current month | -23.08% | ||
1 month | -21.79% |
![Extreme 2.745](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 18-04-09 |
Director of Finance/CFO | 42 | 21-07-05 | |
Shmuel Gov
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uri Geiger
CHM | Chairman | 56 | 18-05-28 |
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 18-04-09 |
Director/Board Member | 60 | 18-05-28 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B | |
+11.28% | 28.12B |
- Stock Market
- Equities
- SSKN Stock
- E2O Stock